08:05 AM EST, 11/14/2025 (MT Newswires) -- Zimmer Biomet Holdings ( ZBH ) said Friday it has received 510(k) clearance from the US Food and Drug Administration for Rosa Knee with OptimiZe, an upgraded version of its ROSA Knee System designed to provide surgeons with "a more customized experience" during robotic-assisted total knee replacement surgery.

Zimmer Biomet ( ZBH ) said it will begin a targeted release of Rosa Knee with OptimiZe later this year, with commercial availability in the US expected in the first quarter of 2026.